Videos
Nick Calla, RPh, vice president of Industry Relations at Cardinal Health Specialty Solutions, discusses specialty areas experiencing innovative developments in therapies.
Thom Cohn, Chief Strategy Officer, Asembia, discusses special considerations for the launch of a personalized drug.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Phentolamine Eye Drop for Presbyopia in Adults
2
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
3
Fixed-Dose 4F-PCC for Reversal of Anticoagulation: Safety, Efficiency, and Cost Savings
4
Feeling Like a Fraud in a Field of Experts: Impostor Syndrome in Oncology Pharmacy
5